CIK 0001527352 · <br>Emerging growth company
Nexalin Technology, Inc.
Sign in to watch- Ticker
- NXL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275566468
- Phone
- (832) 260-0222
- Business address
- 1776 YORKTOWN, SUITE 550, HOUSTON, TX, 77056
- 8-K Event Delisting notice
- DEF 14A Proxy Proxy Statement
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 4/A Open-market buy Director bought 2,500 shares at $4.15 ($10,375)
- 4/A Open-market buy President/CEO bought 25,000 shares at $4.15 ($103,750)
- 4/A Open-market buy Director bought 2,500 shares at $4.15 ($10,375)
- 3/A Insider 3/A
- 3/A Insider 3/A
- 8-K Event Material agreement
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- 10-Q Report Quarterly Report
- 8-K Event Auditor change
- 4 Open-market buy Ms. Elson serves as CFO bought 9,500 shares at $1.12 ($10,640)
Page 8 of 11 · 206 filings